nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Stevens-Johnson syndrome—Amprenavir—acquired immunodeficiency syndrome	0.0081	0.0081	CcSEcCtD
Levobunolol—Cardiac failure congestive—Zidovudine—acquired immunodeficiency syndrome	0.00804	0.00804	CcSEcCtD
Levobunolol—Respiratory failure—Ritonavir—acquired immunodeficiency syndrome	0.00795	0.00795	CcSEcCtD
Levobunolol—Diabetes mellitus—Indinavir—acquired immunodeficiency syndrome	0.0078	0.0078	CcSEcCtD
Levobunolol—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.00716	0.00716	CcSEcCtD
Levobunolol—Cardiac failure congestive—Efavirenz—acquired immunodeficiency syndrome	0.00707	0.00707	CcSEcCtD
Levobunolol—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.00693	0.00693	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Nevirapine—acquired immunodeficiency syndrome	0.00664	0.00664	CcSEcCtD
Levobunolol—Diabetes mellitus—Ritonavir—acquired immunodeficiency syndrome	0.00652	0.00652	CcSEcCtD
Levobunolol—Conjunctivitis—Nevirapine—acquired immunodeficiency syndrome	0.00651	0.00651	CcSEcCtD
Levobunolol—Depression—Stavudine—acquired immunodeficiency syndrome	0.00645	0.00645	CcSEcCtD
Levobunolol—Diplopia—Efavirenz—acquired immunodeficiency syndrome	0.00641	0.00641	CcSEcCtD
Levobunolol—Depression—Abacavir—acquired immunodeficiency syndrome	0.00635	0.00635	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Abacavir—acquired immunodeficiency syndrome	0.00632	0.00632	CcSEcCtD
Levobunolol—Conjunctivitis—Stavudine—acquired immunodeficiency syndrome	0.00629	0.00629	CcSEcCtD
Levobunolol—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.00627	0.00627	CcSEcCtD
Levobunolol—Lethargy—Delavirdine—acquired immunodeficiency syndrome	0.00626	0.00626	CcSEcCtD
Levobunolol—Conjunctivitis—Abacavir—acquired immunodeficiency syndrome	0.00619	0.00619	CcSEcCtD
Levobunolol—Diplopia—Delavirdine—acquired immunodeficiency syndrome	0.00613	0.00613	CcSEcCtD
Levobunolol—Ataxia—Efavirenz—acquired immunodeficiency syndrome	0.00603	0.00603	CcSEcCtD
Levobunolol—Alopecia—Didanosine—acquired immunodeficiency syndrome	0.00591	0.00591	CcSEcCtD
Levobunolol—Visual disturbance—Saquinavir—acquired immunodeficiency syndrome	0.00576	0.00576	CcSEcCtD
Levobunolol—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.00568	0.00568	CcSEcCtD
Levobunolol—Diplopia—Ritonavir—acquired immunodeficiency syndrome	0.00567	0.00567	CcSEcCtD
Levobunolol—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00559	0.00559	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Zidovudine—acquired immunodeficiency syndrome	0.00557	0.00557	CcSEcCtD
Levobunolol—Lethargy—Saquinavir—acquired immunodeficiency syndrome	0.00557	0.00557	CcSEcCtD
Levobunolol—Cerebrovascular accident—Saquinavir—acquired immunodeficiency syndrome	0.00557	0.00557	CcSEcCtD
Levobunolol—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.00551	0.00551	CcSEcCtD
Levobunolol—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.00541	0.00541	CcSEcCtD
Levobunolol—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00533	0.00533	CcSEcCtD
Levobunolol—Ataxia—Ritonavir—acquired immunodeficiency syndrome	0.00533	0.00533	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Indinavir—acquired immunodeficiency syndrome	0.00518	0.00518	CcSEcCtD
Levobunolol—Ataxia—Saquinavir—acquired immunodeficiency syndrome	0.00513	0.00513	CcSEcCtD
Levobunolol—Alopecia—Abacavir—acquired immunodeficiency syndrome	0.00505	0.00505	CcSEcCtD
Levobunolol—Depression—Efavirenz—acquired immunodeficiency syndrome	0.00492	0.00492	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Efavirenz—acquired immunodeficiency syndrome	0.0049	0.0049	CcSEcCtD
Levobunolol—Erectile dysfunction—Delavirdine—acquired immunodeficiency syndrome	0.00488	0.00488	CcSEcCtD
Levobunolol—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.00477	0.00477	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Delavirdine—acquired immunodeficiency syndrome	0.00468	0.00468	CcSEcCtD
Levobunolol—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00468	0.00468	CcSEcCtD
Levobunolol—Conjunctivitis—Delavirdine—acquired immunodeficiency syndrome	0.00459	0.00459	CcSEcCtD
Levobunolol—Erectile dysfunction—Ritonavir—acquired immunodeficiency syndrome	0.00451	0.00451	CcSEcCtD
Levobunolol—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00444	0.00444	CcSEcCtD
Levobunolol—Depression—Ritonavir—acquired immunodeficiency syndrome	0.00436	0.00436	CcSEcCtD
Levobunolol—Erectile dysfunction—Saquinavir—acquired immunodeficiency syndrome	0.00434	0.00434	CcSEcCtD
Levobunolol—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00432	0.00432	CcSEcCtD
Levobunolol—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.00427	0.00427	CcSEcCtD
Levobunolol—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00427	0.00427	CcSEcCtD
Levobunolol—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.00425	0.00425	CcSEcCtD
Levobunolol—Depression—Saquinavir—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Levobunolol—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00417	0.00417	CcSEcCtD
Levobunolol—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.00415	0.00415	CcSEcCtD
Levobunolol—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.00409	0.00409	CcSEcCtD
Levobunolol—Pain—Didanosine—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Levobunolol—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00401	0.00401	CcSEcCtD
Levobunolol—Depression—Lamivudine—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Levobunolol—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Levobunolol—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Levobunolol—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.00392	0.00392	CcSEcCtD
Levobunolol—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00386	0.00386	CcSEcCtD
Levobunolol—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00384	0.00384	CcSEcCtD
Levobunolol—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Levobunolol—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00378	0.00378	CcSEcCtD
Levobunolol—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Levobunolol—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00374	0.00374	CcSEcCtD
Levobunolol—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00374	0.00374	CcSEcCtD
Levobunolol—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Levobunolol—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Levobunolol—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Levobunolol—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Levobunolol—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Levobunolol—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Levobunolol—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Levobunolol—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Levobunolol—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00364	0.00364	CcSEcCtD
Levobunolol—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00362	0.00362	CcSEcCtD
Levobunolol—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Levobunolol—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Levobunolol—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Levobunolol—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00357	0.00357	CcSEcCtD
Levobunolol—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00357	0.00357	CcSEcCtD
Levobunolol—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00354	0.00354	CcSEcCtD
Levobunolol—Pain—Stavudine—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Levobunolol—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Levobunolol—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00352	0.00352	CcSEcCtD
Levobunolol—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Levobunolol—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00348	0.00348	CcSEcCtD
Levobunolol—Pain—Abacavir—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Levobunolol—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00346	0.00346	CcSEcCtD
Levobunolol—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Levobunolol—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Levobunolol—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Levobunolol—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Levobunolol—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Levobunolol—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Levobunolol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Levobunolol—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Levobunolol—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00334	0.00334	CcSEcCtD
Levobunolol—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Levobunolol—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Levobunolol—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Levobunolol—Shock—Indinavir—acquired immunodeficiency syndrome	0.00328	0.00328	CcSEcCtD
Levobunolol—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00328	0.00328	CcSEcCtD
Levobunolol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Levobunolol—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Levobunolol—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Levobunolol—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Levobunolol—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00323	0.00323	CcSEcCtD
Levobunolol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00322	0.00322	CcSEcCtD
Levobunolol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Levobunolol—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00318	0.00318	CcSEcCtD
Levobunolol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00318	0.00318	CcSEcCtD
Levobunolol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00315	0.00315	CcSEcCtD
Levobunolol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00314	0.00314	CcSEcCtD
Levobunolol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Levobunolol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Levobunolol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Levobunolol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00306	0.00306	CcSEcCtD
Levobunolol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00306	0.00306	CcSEcCtD
Levobunolol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Levobunolol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Levobunolol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Levobunolol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Levobunolol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Levobunolol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Levobunolol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00299	0.00299	CcSEcCtD
Levobunolol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00299	0.00299	CcSEcCtD
Levobunolol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Levobunolol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Levobunolol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Levobunolol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Levobunolol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Levobunolol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Levobunolol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Levobunolol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Levobunolol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Levobunolol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Levobunolol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00291	0.00291	CcSEcCtD
Levobunolol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00291	0.00291	CcSEcCtD
Levobunolol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00289	0.00289	CcSEcCtD
Levobunolol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Levobunolol—Pain—Indinavir—acquired immunodeficiency syndrome	0.00285	0.00285	CcSEcCtD
Levobunolol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00285	0.00285	CcSEcCtD
Levobunolol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Levobunolol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Levobunolol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Levobunolol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Levobunolol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Levobunolol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Levobunolol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Levobunolol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Levobunolol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Levobunolol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Levobunolol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Levobunolol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00275	0.00275	CcSEcCtD
Levobunolol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00274	0.00274	CcSEcCtD
Levobunolol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00274	0.00274	CcSEcCtD
Levobunolol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Levobunolol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00271	0.00271	CcSEcCtD
Levobunolol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Levobunolol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Levobunolol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Levobunolol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Levobunolol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00268	0.00268	CcSEcCtD
Levobunolol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00267	0.00267	CcSEcCtD
Levobunolol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Levobunolol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Levobunolol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Levobunolol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Levobunolol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00259	0.00259	CcSEcCtD
Levobunolol—Headache—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Levobunolol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Levobunolol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Levobunolol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00257	0.00257	CcSEcCtD
Levobunolol—Headache—Abacavir—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Levobunolol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Levobunolol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Levobunolol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Levobunolol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Levobunolol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Levobunolol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Levobunolol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Levobunolol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Levobunolol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Levobunolol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Levobunolol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Levobunolol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Levobunolol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Levobunolol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Levobunolol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Levobunolol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Levobunolol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Levobunolol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Levobunolol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Levobunolol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00237	0.00237	CcSEcCtD
Levobunolol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Levobunolol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.00232	CcSEcCtD
Levobunolol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Levobunolol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Levobunolol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Levobunolol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00228	0.00228	CcSEcCtD
Levobunolol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00228	0.00228	CcSEcCtD
Levobunolol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Levobunolol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Levobunolol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Levobunolol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Levobunolol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Levobunolol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Levobunolol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0022	0.0022	CcSEcCtD
Levobunolol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Levobunolol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00216	0.00216	CcSEcCtD
Levobunolol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Levobunolol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Levobunolol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Levobunolol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Levobunolol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00211	0.00211	CcSEcCtD
Levobunolol—Headache—Indinavir—acquired immunodeficiency syndrome	0.00209	0.00209	CcSEcCtD
Levobunolol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Levobunolol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Levobunolol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00205	CcSEcCtD
Levobunolol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00203	0.00203	CcSEcCtD
Levobunolol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.002	0.002	CcSEcCtD
Levobunolol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Levobunolol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Levobunolol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Levobunolol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Levobunolol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Levobunolol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Levobunolol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Levobunolol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Levobunolol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Levobunolol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Levobunolol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Levobunolol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Levobunolol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Levobunolol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Levobunolol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00181	0.00181	CcSEcCtD
Levobunolol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Levobunolol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00177	0.00177	CcSEcCtD
Levobunolol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Levobunolol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Levobunolol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00169	0.00169	CcSEcCtD
Levobunolol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Levobunolol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Levobunolol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Levobunolol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Levobunolol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
